Latest AI and machine learning research in genetics for healthcare professionals.
Predicting variant-drug interactions is essential for advancing precision medicine across therapeutic areas. The Pharmacogenomics Knowledge Base (PharmGKB) dataset, with ~11,000 samples, is underutilized in machine learning (ML) due to its limited size. After filtering for variant mappings and excluding metabolizer-related conditions, we obtain ~4,000 samples for a six-class prediction task (incre...
Epistasis causes an individual’s genetic background to modulate a DNA variant’s effect on trait [1–6]. Epistatic interactions among different loci in human complex traits are expected to be widespread but have not been found [7]. This could be due to small interaction effect sizes, the statistical complexity of estimating interactions that is higher than marginal variant effects, and a substantial...
Genome sequencing (GS) enables the accurate identification of genetic variants in most genomic regions and is rapidly transforming routine diagnostics...
Myotonic Dystrophy Type 1 (DM1), the most common genetic neuromuscular disorder in adults, poses significant challenges for drug development due to it...
Scoliosis is the most common developmental spinal deformity, but its genetic underpinnings remain only partially understood. To enhance the identifica...
This study evaluated the prognostic performance of RlapsRisk BC, a multimodal deep learning tool designed to predict distant recurrence-free interval ...
Heart failure (HF) is a life-threatening syndrome with significant morbidity and mortality. While evidence-based drug treatments have effectively redu...
Acute lymphoblastic leukemia is a highly heterogeneous hematologic malignancy that poses significant challenges for clinicians in terms of early detec...
To systematically identify causal genetic mechanisms that confer risk for coronary artery disease (CAD) in GWAS loci, we mapped genome-wide variant-to...
Musculoskeletal (MSK) modeling and ultrasound imaging (USI) are complementary techniques that, when combined with three-dimensional gait analysis (3DG...
Standard durations of direct acting antivirals (DAAs; 8–12 weeks) can be a barrier to HCV treatment initiation and completion among marginalised popul...
Disrupted brain iron metabolism and activated ferroptosis during ageing constitute significant precursors to neurodegenerative diseases. However, whet...
To evaluate how recent advances in deep learning can improve the construction of quantitative phenotypes for genome-wide association studies (GWAS), w...
Early detection of autism spectrum disorder (ASD) improves outcomes, yet clinical assessment is time-intensive. Artificial intelligence (AI) may suppo...
Tuberculosis remains a major health threat, infecting nearly a third of the world’s population. Of those infected, 5-10% progress from latent infectio...
The availability of effective antiretroviral therapy has made HIV manageable, provided patients have consistent access to routine viral load (VL) test...
Gestational diabetes mellitus (GDM) affects 15.6% of pregnancies globally, with Vietnam exhibiting one of the highest prevalences at 21%. Current diag...
Parent/patient-reported datasets provide ready access to phenotypic data for monogenic neurodevelopmental disorders yet their concordance with clinica...
Genome-wide association studies (GWAS) of coronary artery disease (CAD), the leading cause of mortality and morbidity globally, have identified approx...
Polygenic scores (PGSs) are widely used to translate genome-wide association study (GWAS) findings into tools for genetic risk prediction. Most curren...